Pioneering figures in medicine: Albert Bruce Sabin- inventor of the oral polio vaccine

Kurume Medical Journal

Volumn 52, Issue 3, 2005, Pages 111-116

  Smith, Derek R ^a   Leggat, Peter A ^b  

^a NATL INSTITUTE OF INDUSTRIAL HEALTH   (Japan)

^b JAMES COOK UNIVERSITY   (Australia)

Author keywords

Albert Sabin; Medical history; Polio; Public health; Vaccine

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

EPIDEMIOLOGICAL DATA; HISTORY OF MEDICINE; HUMAN; INCIDENCE; MEDICAL RESEARCH; POLIOMYELITIS; POLIOMYELITIS VIRUS; REVIEW; VACCINATION; VACCINE PRODUCTION; WORLD HEALTH ORGANIZATION;

HISTORY, 20TH CENTURY; POLAND; POLIOVIRUS VACCINE, ORAL;

EID: 32844467776     PISSN: 00235679     EISSN: None     Source Type: Journal    
DOI: 10.2739/kurumemedj.52.111     Document Type: Review

References (28)

1. Aylward B, Hennessey KA, Zagaria N, Olive JM, and Cochi S. When is a disease eradicable? 100 years of lessons learned. Am J Pub Health 2000; 90:1515-1520.
2. Melnick JL, and Horaud F. Albert B Sabin. Biologicals 1993; 21:299-303.
3. MacLaughlin S. Dr. Albert Sabin. Prim Care Update Ob Gyns 2003; 10:129-130.
4. Melnick JL. Current status of poliovirus infections. Clin Microbiol Rev 1996; 9:293-300.
5. Melnick JL. The discovery of the enteroviruses and the classification of polioviruses among them. Biologicals 1993; 21:305-309.
6. Horaud F. Albert B. Sabin and the development of oral poliovaccine. Biologicals 1993; 21:311-316.
7. Sabin AB. Purification of poliomyelitis virus by adsorption and elution. Proc Soc Exp Biol Med 1931; 29:59-62.
8. Melnick JL, and Penner LR. The survival of poliomyelitis and Coxsackie viruses following their ingestion by flies. J Exp Med 1952; 96:255-271.
9. Sabin AB. Transitory appearance of type 2 neutralizing antibody in patients infected with type 1 poliomyelitis virus. J Exp Med 1952; 96:99-106.
10. Winsser J, and Sabin AB. Levels of homotypic neutralizing antibody in human poliomyelitis three years after infection. J Exp Med 1952; 96:477-490.
11. Sabin AB, Hennessen WA, and Winsser J. Studies on variants of poliomyelitis virus (I): Experimental segregation and properties of avirulent variants of three immunologic types. J Exp Med 1954; 99:551-576.
12. Baker JP. Immunization and the American way: 4 childhood vaccines. Am J Pub Health 2000; 90:199-207.
13. Kleiss KM. Dr. Jonas Salk. Prim Care Update Ob Gyns 2003; 10:127-128.
14. Hinman AR. Mass vaccination against Polio. J Am Med Assoc 1984; 251:2994-2996.
15. de Quadros CA, and Henderson DA. Disease eradication and control in the Americas. Biologicals 1993; 21:335-343.
16. Minor PD, Macadam AJ, Stone DM, and Almond JW. Genetic basis of attenuation of the Sabin oral poliovirus vaccines. Biologicals 1993; 21:357-363.
17. Sabin AB, Ramos-Alvarez M, Alvarez-Amezquita J, Pelon W, Michaels RH et al. Live, orally given poliovirus vaccine. Effects of rapid mass immunization on population under conditions of massive enteric infection with other viruses. J Am Med Assoc 1960; 173:1521-1526.
18. Sabin AB, Ramos-Alvarez M, Alvarez-Amezquita J, Pelon W, Michaels RH et al. Live, orally given poliovirus vaccine. Effects of rapid mass immunization on population under conditions of massive enteric infection with other viruses. J Am Med Assoc 1984; 251:2988-2993.
19. Sabin AB, Ramos-Alvarez M, Alvarez-Amezquita J, Pelon W, Michaels RH et al. Live, orally given poliovirus vaccine. Effects of rapid mass immunization on population under conditions of massive enteric infection with other viruses. Bull World Health Organ 1999; 77:196-201.
20. Agol VI, and Drozdov SG. Russian contribution to OPV. Biologicals 1993; 21:321-325.
21. Ward NA, Milstien JB, Hull HF, Hull BP, and Kim-Farley RJ. The WHO-EPI initiative for the global eradication of poliomyelitis. Biologicals 1993; 21:327-333.
22. Magrath D, and Reeve P. On the role of the World Health Organization in the development of Sabin vaccines. Biologicals 1993; 21:345-348.
23. Racaniello VR. Infectious cDNA, cell receptors and transgenic mice in the study of Sabin's poliovirus vaccines. Biologicals 1993; 21:365-369.
24. Wimmer E, and Nomoto A. Molecular biology and cell-free synthesis of poliovirus. Biologicals 1993; 21:349-356.
25. Girard M, Martin A, and van der Werf S. Potential use of poliovirus as a vector. Biologicals 1993; 21:371-377.
26. Sabin AB. Reflections on the qualitative and quantitative aspects of neurovirulence of different polioviruses. Biologicals 1993; 21:317-320.
27. Grouse LD. Obituary: Albert Bruce Sabin. J Am Med Assoc 1993; 269:2140.
28. Dowdle WR. The principles of disease elimination and eradication. Bull World Health Organ 1998; 76 (Suppl 2):22-25.